News
Researchers working on a COVID-19 vaccine are facing a race against time due to falling rates of the virus threatening the testing process of their...
A new study from the Massachusetts Institute of Technology, Harvard, Virginia Tech and the University of Connecticut has shown that hot and humid...
The FDA has approved Takeda’s Alunbrig (brigatinib) for adult patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung...
UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the COVID-19 pandemic, acknowledging the...
The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, due to...
The findings provide hope for the idea that the immune system could potentially provide immunity to COVID-19 reinfection, buoying hopes that an...
A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK.
About a quarter of the world’s population are at higher risk of catching the COVID-19 coronavirus due to a lack of access to proper sanitation.
Scientists at the Lawrence Berkeley National Laboratory are launching a project to apply machine learning methods to map the severity, distribution...
AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration with...
